B. Shi

发表

Development of self-assembling peptide nanovesicle with bilayers for enhanced EGFR-targeted drug and gene delivery.

Jianren Gu, Dejin Jiao, Xiaofei Liang, 2016, Biomaterials.

Development of efficient RNA interference system using EGF-displaying phagemid particles

B. Shi, J. Gu, Jie Zhang, 2008, Acta Pharmacologica Sinica.

Application of EGFP-EGF fusions to explore mechanism of endocytosis of epidermal growth factor

B. Shi, Yuhong Xu, J. Gu, 2007, Acta Pharmacologica Sinica.

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.

Y. Liu, B. Shi, Mingliang Fan, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors

B. Shi, Zonghai Li, Hua Jiang, 2022, Molecular therapy oncolytics.

Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells

B. Shi, Zonghai Li, Hua Jiang, 2019, Front. Oncol..

EGFRvIII Mediates Hepatocellular Carcinoma Cell Invasion by Promoting S100 Calcium Binding Protein A11 Expression

Hailong Xie, B. Shi, Zonghai Li, 2013, PloS one.

An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression

Jianren Gu, B. Shi, Zonghai Li, 2014, Cancer Immunology, Immunotherapy.

Growth and metastasis suppression of glioma xenografts expressing exon 4‐deletion variant of epidermal growth factor receptor by monoclonal antibody CH12‐mediated receptor degradation

B. Shi, Zonghai Li, M. Yao, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A Novel Magneto-fluorescent Nano-bioprobe for Cancer Cell Targeting, Imaging and Collection

B. Shi, Zonghai Li, M. Chu, 2011, Applied biochemistry and biotechnology.

An IL-4/21 Inverted Cytokine Receptor Improving CAR-T Cell Potency in Immunosuppressive Solid-Tumor Microenvironment

B. Shi, Zonghai Li, Hua Jiang, 2019, Front. Immunol..

Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III*

Jianren Gu, B. Shi, Zonghai Li, 2010, The Journal of Biological Chemistry.

Identification and characterization of Ch806 mimotopes

Jinjun Li, B. Shi, Zonghai Li, 2010, Cancer Immunology, Immunotherapy.

The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III

B. Shi, J. Gu, Zonghai Li, 2018, Cellular Physiology and Biochemistry.

The activation of Toll‐like receptor 4 reverses tumor differentiation in human glioma U251 cells via Notch pathway

Chuang Yuan, Xueting Liu, B. Shi, 2018, International immunopharmacology.

Protein III-based single-chain antibody phage display using bacterial cells bearing an additional genome of a gene-III-lacking helper phage.

B. Shi, Zonghai Li, Yuhong Xu, 2007, BioTechniques.

The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.

B. Shi, Zonghai Li, J. Kong, 2014, Cancer letters.

Better Gene Expression by (−)Gene than by (+)Gene in Phage Gene Delivery Systems

B. Shi, Zonghai Li, Yuhong Xu, 2006, Biotechnology progress.

Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular Carcinoma.

B. Shi, Zonghai Li, Ying Liu, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion

B. Shi, Zonghai Li, Hua Jiang, 2020, Clinical Cancer Research.

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer.

B. Shi, Zonghai Li, Honghong Zhang, 2018, Journal of the National Cancer Institute.

Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3–Targeted Chimeric Antigen Receptor–Engineered T Cells in Hepatocellular Carcinoma

B. Shi, Zonghai Li, Ying Liu, 2019, The Journal of Immunology.

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

B. Shi, J. Gu, Zonghai Li, 2014, Clinical Cancer Research.

Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma

B. Shi, Zonghai Li, Kesang Li, 2017, Cancer Immunology, Immunotherapy.

EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1.

B. Shi, J. Gu, Zonghai Li, 2016, Cancer letters.

Synergistic antitumor efficacy against the EGFRvIII+HER2+ breast cancers by combining trastuzumab with anti-EGFRvIII antibody CH12

B. Shi, J. Gu, Zonghai Li, 2015, Oncotarget.

Olaparib Suppresses MDSC Recruitment via SDF1α/CXCR4 Axis to Improve the Anti-tumor Efficacy of CAR-T Cells on Breast Cancer in Mice.

B. Shi, Zonghai Li, Honghong Zhang, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer

B. Shi, H. Sun, P. Zhang, 2014, Cell Death and Disease.

Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma

B. Shi, Zonghai Li, Shengli Yang, 2015, Oncotarget.

Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer

Jianren Gu, B. Shi, Zonghai Li, 2010, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery

Xiaofei Liang, B. Shi, Mingliang Fan, 2016, Journal of drug targeting.

Design and biological activity of epidermal growth factor receptor-targeted peptide doxorubicin conjugate.

Xiaofei Liang, B. Shi, Mingliang Fan, 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice.

B. Shi, Zonghai Li, Hua Jiang, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN− glioblastoma in vivo

B. Shi, J. Gu, Zonghai Li, 2016, Oncotarget.

Cancer Therapy : Preclinical Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Jianren Gu, B. Shi, Zonghai Li, 2014 .

The Monoclonal Antibody CH 12 Enhances the Sorafenib-Mediated Growth Inhibition of Hepatocellular Carcinoma Xenografts Expressing Epidermal Growth Factor Receptor Variant III 1

B. Shi, Zonghai Li, M. Yao, 2014 .

The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.

B. Shi, Zonghai Li, M. Yao, 2012, Neoplasia.

Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity.

Jianren Gu, Y. Mao, Yinghao Sun, 2011, Neoplasia.

A novel EGFR isoform confers increased invasiveness to cancer cells.

Jianren Gu, Hong-Yang Wang, B. Shi, 2013, Cancer research.

Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.

Jianren Gu, B. Shi, Zonghai Li, 2009, Cancer letters.

Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell

B. Shi, Zonghai Li, J. Kong, 2018, Cancer Immunology Research.

A Fusion Receptor as a Safety Switch, Detection, and Purification Biomarker for Adoptive Transferred T Cells.

B. Shi, J. Gu, Zonghai Li, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.

B. Shi, Zonghai Li, Haiyan Zhang, 2013, Carcinogenesis.

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Hua Jiang, Min Zhou, Hong Luo, 2018, Front. Pharmacol..

Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1–CH3 fusion protein

Y. Liu, B. Shi, Zonghai Li, 2018, Cancer Immunology, Immunotherapy.

Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells

B. Shi, Zonghai Li, Hua Jiang, 2019, Front. Oncol..

Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR-T cells

B. Shi, Mingliang Fan, Zonghai Li, 2017, Protein & Cell.

Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-κB/Icam1 signaling.

B. Shi, Zonghai Li, Hua Jiang, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

Weak binding to E3 ubiquitin ligase c‐Cbl increases EGFRvA protein stability

B. Shi, Zonghai Li, Biao Wang, 2016, FEBS letters.

Chlorambucil gemcitabine conjugate nanomedicine for cancer therapy.

Xiaofei Liang, B. Shi, Mingliang Fan, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer

B. Shi, Zonghai Li, Biao Wang, 2017, Molecular Cancer.

FAP-targeted CAR-T suppresses MDSCs recruitment to improve the antitumor efficacy of claudin18.2-targeted CAR-T against pancreatic cancer

B. Shi, Zonghai Li, Hua Jiang, 2023, Journal of Translational Medicine.

Enforced expression of Runx3 improved CAR-T cell potency in solid tumor via enhancing resistance to activation-induced cell death.

B. Shi, Zonghai Li, Honghong Zhang, 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12

B. Shi, Zonghai Li, Hua Jiang, 2019, Frontiers of Medicine.

EGFR modulates monounsaturated fatty acid synthesis through phosphorylation of SCD1 in lung cancer

B. Shi, Zonghai Li, Biao Wang, 2017, Molecular Cancer.

A novel EGFR isoform confers increased invasiveness to cancer cells.

Hong-Yang Wang, B. Shi, Zonghai Li, 2013, Cancer research.

GPC3-targeted CAR-T cells expressing GLUT1 or AGK exhibit enhanced antitumor activity against hepatocellular carcinoma.

B. Shi, Hua Jiang, Yansha Sun, 2024, Acta pharmacologica Sinica.